Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1302775
                    [Title] => Drug for blood clot-related conditions approved in Phl
                    [Summary] => 
A breakthrough drug in treating life-threatening post-orthopaedic venous thromboembolism (VTE) has been made available in the Philippines, following the recent approval of Pfizer’s treatment, which is reported to reduce the risk of complications after surgery in adults.

                    [DatePublished] => 2014-03-20 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

FACTOR XA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1302775
                    [Title] => Drug for blood clot-related conditions approved in Phl
                    [Summary] => 
A breakthrough drug in treating life-threatening post-orthopaedic venous thromboembolism (VTE) has been made available in the Philippines, following the recent approval of Pfizer’s treatment, which is reported to reduce the risk of complications after surgery in adults.

                    [DatePublished] => 2014-03-20 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Drug for blood clot-related conditions approved in Phl

March 20, 2014 - 12:00am

A breakthrough drug in treating life-threatening post-orthopaedic venous thromboembolism (VTE) has been made available in the Philippines, following the recent approval of Pfizer’s treatment, which is reported...

Science and Environment